Latest ESRD Stories
An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients.
Newly published research shows that more patients with end-stage renal disease (ESRD) caused by lupus nephritis choose hemodialysis as their initial kidney replacement therapy over peritoneal dialysis and preemptive kidney transplantation.
Even though overall black patients have a lower risk of death while receiving dialysis than white patients, this applies primarily to older adults, as black patients younger than 50 years of age have a significantly higher risk of death.
Researchers have recently published some promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy.
Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes.